| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director
2 companies
Francis Richard D is a President and CEO at TEVA, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 14 sales. Those positions are worth an estimated $40.4M at current prices.
Our model assigns Francis Richard D a below-average insider score of 23/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -73.3%.
Francis Richard D's largest disclosed position is in TEVA as President and CEO, worth about $40.4M. The recent filings there lean toward selling, a net 1,176,496 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | TEVA Teva Pharmaceutical Industries Limited | President and CEO | Sale+OE10b5-1 | 6,153 | $34.35 | $211,355.55 | -0.5% | +7.1% | - | |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Limited | President and CEO | Sale+OE10b5-1 | 20,025 | $31.67 | $634,159.71 | -1.7% | +3.4% | - | |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Limited | President and CEO | Sale+OE10b5-1 | 23,393 | $32.46 | $759,442.05 | -2.0% | +0.5% | - | |
| Mar 3, 2026 | TEVA Teva Pharmaceutical Industries Limited | President and CEO | Sale+OE10b5-1 | 442,935 | $32.36 | $14,333,332.31 | -28.3% | +7.3% | - | |
| Feb 15, 2026 | TEVA Teva Pharmaceutical Industries Limited | President and CEO | Sale+OE10b5-1 | 447,778 | $34.22 | $15,324,799.05 | -42.5% | -0.3% | - | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | President and CEO | Sale+OE10b5-1 | 23,773 | $15.80 | $375,533.70 | -8.0% | +8.1% | +99.7% | |
| Mar 4, 2025 | TEVA Teva Pharmaceutical Industries Ltd | President and CEO | Sale+OE10b5-1 | 31,342 | $16.06 | $503,235.99 | -11.3% | +10.0% | +109.8% | |
| Feb 18, 2025 | TEVA Teva Pharmaceutical Industries Ltd | President and CEO | Sale+OE10b5-1 | 75,506 | $16.95 | $1,279,660.59 | -26.5% | +2.7% | +105.9% | |
| Mar 4, 2024 | TEVA Teva Pharmaceutical Industries Ltd | President and CEO | Sale+OE10b5-1 | 31,061 | $13.34 | $414,269.88 | -20.1% | +26.3% | +16.7% | |
| Feb 15, 2024 | TEVA Teva Pharmaceutical Industries Ltd | President and CEO | Sale+OE10b5-1 | 74,530 | $13.15 | $980,173.84 | -46.1% | +27.1% | +23.1% |